Hyderabad: Dr. Reddy's Laboratories is gearing up to shake up the global weight-loss drug market with the launch of an ...

Denmark is investing 80 million euro in a quantum computing project intended to bring a commercial-grade system to the Nordic ...

China's Sciwind Biosciences is in talks with a U.S. company interested in licensing its experimental weight-loss drug for ...

ISLAMABAD: Pakistan can significantly reduce national health expenditure by controlling obesity by creating awareness and ...

Eating disorder centers are facing an influx of people with weight-loss prescriptions. Experts say doctors are ...

European pharmaceutical stocks have swooned while the broader market has climbed higher. As a result, stocks in the sector ...

Aging America may revive healthcare stocks after a rough year — discover why long-term trends point to a powerful rebound.

Telehealth platform Hims & Hers Health (NYSE:HIMS) shot to the top of stock charts yesterday as shares soared 16% high on no company news. While it is revolutionizing access to healthcare by ...

Novo Nordisk NVO -1.23% Get Free Report has outperformed the market over the past 5 years by 1.33% on an annualized basis producing an average annual return of 15.96%. Currently, Novo Nordisk has a ...

Ongoing patent battle between Novo Nordisk and Dr Reddy’s Laboratories over semaglutide export to multiple countries.

Roche Holding AG's H2 2025 earnings show solid growth in pharma revenues but highlight pipeline struggles and U.S. pricing pressures. Click for my RHHBY update.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.